Literature DB >> 2566434

Effect of continuous and intermittent clenbuterol feeding on rat growth rate and muscle.

M A McElligott1, A Barreto, L Y Chaung.   

Abstract

1. The growth response to clenbuterol is a dynamic process. 2. Body weight gain is stimulated within two days of treatment and the effect attenuates by two weeks of treatment. 3. Intermittent feeding prevents the attenuation of the growth response. 4. Muscle weight increased 14-22% by both feeding regimens. 5. Clenbuterol decreased cathepsin B activity in the EDL and gastrocnemius and increased the activity in the soleus after two weeks of continuous clenbuterol treatment.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2566434     DOI： 10.1016/0742-8413(89)90215-6

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Comp Pharmacol Toxicol        ISSN： 0742-8413


  10 in total

1.  Beta2-Agonist Doping Control and Optical Isomer Challenges.

Authors:  Glenn A Jacobson; J Paul Fawcett
Journal:  Sports Med       Date:  2016-12       Impact factor: 11.136

Review 2.  Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue.

Authors:  Y T Yang; M A McElligott
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

3.  Relationship between in vitro relaxation of the costo-uterine smooth muscle and mesovarial leiomyoma formation in vivo by beta-receptor agonists.

Authors:  W E Colbert; B F Wilson; P D Williams; G D Williams
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  Clenbuterol has a greater influence on untrained than on previously trained skeletal muscle in rats.

Authors:  R J Murphy; L Béliveau; K L Seburn; P F Gardiner
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

5.  Ractopamine-induced fiber type-specific gene expression in porcine skeletal muscles is independent of growth.

Authors:  Andrea M Gunawan; Con-Ning Yen; Brian T Richert; Allan P Schinckel; Alan L Grant; David E Gerrard
Journal:  J Anim Sci       Date:  2020-11-01       Impact factor: 3.159

6.  Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma.

Authors:  Yousun Ko; Heeryoel Jeong; Seungwoo Khang; Jeongjin Lee; Kyung Won Kim; Beom-Jun Kim
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

7.  Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle.

Authors:  P R Turner; R Schultz; B Ganguly; R A Steinhardt
Journal:  J Membr Biol       Date:  1993-05       Impact factor: 1.843

8.  Change of skeletal muscle mass in patients with pheochromocytoma.

Authors:  Seung Hun Lee; Mi Kyung Kwak; Seong Hee Ahn; Hyeonmok Kim; Yoon Young Cho; Sunghwan Suh; Kee-Ho Song; Jung-Min Koh; Jae Hyeon Kim; Beom-Jun Kim
Journal:  J Bone Miner Metab       Date:  2018-09-20       Impact factor: 2.626

9.  Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.

Authors:  Daisuke Umeki; Yoshiki Ohnuki; Yasumasa Mototani; Kouichi Shiozawa; Kenji Suita; Takayuki Fujita; Yoshiki Nakamura; Yasutake Saeki; Satoshi Okumura
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.

Authors:  Yoshiki Ohnuki; Daisuke Umeki; Yasumasa Mototani; Kouichi Shiozawa; Megumi Nariyama; Aiko Ito; Naoya Kawamura; Yuka Yagisawa; Huiling Jin; Wenqian Cai; Kenji Suita; Yasutake Saeki; Takayuki Fujita; Yoshihiro Ishikawa; Satoshi Okumura
Journal:  Physiol Rep       Date:  2016-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.